Literature DB >> 27327568

Lymphocyte lineage-specific and developmental stage specific mechanisms suppress cyclin D3 expression in response to DNA double strand breaks.

Amy DeMicco1,2, Tyler Reich1, Rahul Arya1, Adrian Rivera-Reyes1,2, Megan R Fisher1,3, Craig H Bassing1,2,3,4.   

Abstract

Mammalian cells are thought to protect themselves and their host organisms from DNA double strand breaks (DSBs) through universal mechanisms that restrain cellular proliferation until DNA is repaired. The Cyclin D3 protein drives G1-to-S cell cycle progression and is required for proliferation of immature T and B cells and of mature B cells during a T cell-dependent immune response. We demonstrate that mouse thymocytes and pre-B cells, but not mature B cells, repress Cyclin D3 protein levels in response to DSBs. This response requires the ATM protein kinase that is activated by DSBs. Cyclin D3 protein loss in thymocytes coincides with decreased association of Cyclin D3 mRNA with the HuR RNA binding protein that ATM regulates. HuR inactivation reduces basal Cyclin D3 protein levels without affecting Cyclin D3 mRNA levels, indicating that thymocytes repress Cyclin D3 expression via ATM-dependent inhibition of Cyclin D3 mRNA translation. In contrast, ATM-dependent transcriptional repression of the Cyclin D3 gene represses Cyclin D3 protein levels in pre-B cells. Retrovirus-driven Cyclin D3 expression is resistant to transcriptional repression by DSBs; this prevents pre-B cells from suppressing Cyclin D3 protein levels and from inhibiting DNA synthesis to the normal extent following DSBs. Our data indicate that immature B and T cells use lymphocyte lineage- and developmental stage-specific mechanisms to inhibit Cyclin D3 protein levels and thereby help prevent cellular proliferation in response to DSBs. We discuss the relevance of these cellular context-dependent DSB response mechanisms in restraining proliferation, maintaining genomic integrity, and suppressing malignant transformation of lymphocytes.

Entities:  

Keywords:  ATM; Cyclin D3; DNA damage response; HuR; lymphocytes

Mesh:

Substances:

Year:  2016        PMID: 27327568      PMCID: PMC5105912          DOI: 10.1080/15384101.2016.1198861

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  40 in total

1.  A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

Authors:  P P Lee; D R Fitzpatrick; C Beard; H K Jessup; S Lehar; K W Makar; M Pérez-Melgosa; M T Sweetser; M S Schlissel; S Nguyen; S R Cherry; J H Tsai; S M Tucker; W M Weaver; A Kelso; R Jaenisch; C B Wilson
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

Review 2.  Living with or without cyclins and cyclin-dependent kinases.

Authors:  Charles J Sherr; James M Roberts
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

Review 3.  Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from.

Authors:  Avinash Bhandoola; Harald von Boehmer; Howard T Petrie; Juan Carlos Zúñiga-Pflücker
Journal:  Immunity       Date:  2007-06       Impact factor: 31.745

Review 4.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

Review 5.  The ATM protein kinase: regulating the cellular response to genotoxic stress, and more.

Authors:  Yosef Shiloh; Yael Ziv
Journal:  Nat Rev Mol Cell Biol       Date:  2013-03-13       Impact factor: 94.444

6.  The ataxia telangiectasia mutated and cyclin D3 proteins cooperate to help enforce TCRβ and IgH allelic exclusion.

Authors:  Natalie C Steinel; Megan R Fisher; Katherine S Yang-Iott; Craig H Bassing
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

7.  Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

Authors:  J Shaughnessy; A Gabrea; Y Qi; L Brents; F Zhan; E Tian; J Sawyer; B Barlogie; P L Bergsagel; M Kuehl
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

8.  The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.

Authors:  M Cheng; P Olivier; J A Diehl; M Fero; M F Roussel; J M Roberts; C J Sherr
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

9.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

Review 10.  Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling.

Authors:  Marcus R Clark; Malay Mandal; Kyoko Ochiai; Harinder Singh
Journal:  Nat Rev Immunol       Date:  2013-12-31       Impact factor: 53.106

View more
  8 in total

1.  Cyclin D3: To translate or not to translate.

Authors:  J Alan Diehl
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

2.  Immature Lymphocytes Inhibit Rag1 and Rag2 Transcription and V(D)J Recombination in Response to DNA Double-Strand Breaks.

Authors:  Megan R Fisher; Adrian Rivera-Reyes; Noah B Bloch; David G Schatz; Craig H Bassing
Journal:  J Immunol       Date:  2017-02-17       Impact factor: 5.422

3.  Flip the switch: BTG2-PRMT1 protein complexes antagonize pre-B-cell proliferation to promote B-cell development.

Authors:  Glendon S Wu; Craig H Bassing
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

Review 4.  At the intersection of DNA damage and immune responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Nat Rev Immunol       Date:  2019-04       Impact factor: 53.106

Review 5.  Cell cycle RNA regulons coordinating early lymphocyte development.

Authors:  Alison Galloway; Martin Turner
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-02-23       Impact factor: 9.957

6.  DN2 Thymocytes Activate a Specific Robust DNA Damage Response to Ionizing Radiation-Induced DNA Double-Strand Breaks.

Authors:  Irene Calvo-Asensio; Tara Sugrue; Nabil Bosco; Antonius Rolink; Rhodri Ceredig
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

7.  RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex.

Authors:  Deepti Soodgupta; Lynn S White; Wei Yang; Rachel Johnston; Jared M Andrews; Masako Kohyama; Kenneth M Murphy; Nima Mosammaparast; Jacqueline E Payton; Jeffrey J Bednarski
Journal:  Cell Rep       Date:  2019-10-22       Impact factor: 9.995

Review 8.  Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.

Authors:  Zu Ye; Yin Shi; Susan P Lees-Miller; John A Tainer
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.